ARTIMPLANT YEAR-END REPORT JANUARY – DECEMBER 2009

Report this content

Västra Frölunda, Sweden, February 11 2010

• Net revenue for the fourth quarter increased to SEK 5.8 million (4.6) and doubled for the full year to SEK 24.0 million (12.1)* • The net loss for the fourth quarter improved to SEK 5.4 million (6.0) and for the full year the net loss improved to SEK 18.6 million (22.6) • Earnings per share for the fourth quarter improved to SEK -0.09 (-0.10) and for the full year SEK -0.31 (-0.38) • Product sales to end-customers and distributors multiplied to SEK 8.7 million (1.7) for the full year, equivalent to 37% (15) of product sales • Sales of Artelon® Spacer for the fourth quarter amounted to SEK 2.4 million (3.1) and for the full year sales rose to SEK 13.1 million (7.4) • Sales of Artelon® Tissue Reinforcement for the fourth quarter increased to SEK 3.3 million (1.6) and for the full year to SEK 10.2 million (4.1) • Goal to reach positive cash flow before changes in working capital, at a monthly basis, towards the end of 2010 • The Board proposes that no dividend be paid for 2009 N.B. This is a translation from Swedish. The Swedish version shall always take precedence. Artimplant will hold a telephone conference by reason of this report on February 11, 2010 at 11 am (CET). For further information see www.artimplant.com. * Figures in brackets refer to the corresponding period last year